Get to know our clinical trials

Clinical trial of GEN1078 in participants with malignant solid tumors.

THE AIM OF THIS STUDY IS TO FIND OUT IF THE TRIAL DRUG IS SAFE IN PARTICIPANTS WITH CERTAIN TYPES OF CANCER AND TO FIND OUT WHAT IS THE BEST DOSE.

Imagen de la Dra. Esperanza Rodríguez Ruiz, especialista en oncología radioterápica de la Clínica Universidad de Navarra
Dr. María Rodríguez Ruiz [SP] Curriculum
Specialist Radiotherapeutic Oncology Department
Navarre headquarters
Cancer Center
Liver and Pancreatic Cancer Area
Status
In recruitment
headquarters
Pamplona

Technical Summary

  • FIRST-IN-HUMAN, OPEN-LABEL, DOSE-ESCALATION, EXPANSION COHORT CLINICAL TRIAL TO EVALUATE THE SAFETY AND PRELIMINARY EFFICACY OF GEN1078 IN PARTICIPANTS WITH MALIGNANT SOLID TUMORS
  • Code EudraCT: 2024-515752-21-00
  • Protocol number: GCT1078-01
  • Promoter: Genmab A/S
  • Molecule/Drug: GEN1078

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial

I want to make an appointment
Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.

I WANT TO REQUEST A SECOND OPINION